Advertisement

Medikamentöse Interaktionen in der Aufwachphase

  • R. Dennhardt
Part of the Klinische Anästhesiologie und Intensivtherapie book series (KAI, volume 24)

Zusammenfassung

Während der Aufwachphase kommt es zum Zusammentreffen verschiedenster pathophysiologischer und pharmakologischer Einflüsse. Veränderungen der Kreislaufreaktion, Zunahme oder Abnahme der Durchblutung einzelner Organe und Veränderungen der Größe der Flüssigkeitskompartimente beeinflussen das pharmakokinetische Verhalten der im Umfeld der Narkose applizierten Pharmaka. Unterschiedliche Medikamente treffen an Rezeptoren zusammen und vermögen additive, synergistische, potenzierende oder antagonistische Wirkungen hervorzurufen.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Booij, L. H. D. J., Miller, R. D., Crul, J. F.: Neostigmine and 4-aminopyridine antagonism of lincomycin-pancuronium neuromuscular blockade in man. Anesth. Anaig. Curr. Res. 57, 316 (1978).Google Scholar
  2. 2.
    Branch, R. A., Shand, D. G., Wilkinson, G. R., Nies, A. S.: Increased clearance of antipyrine and d-propranolol after phenobarbital treatment in the monkey. Relative contributions of enzyme induction and increased hepatic bloodflow. J. clin. Invest. 53, 1101 (1974).PubMedCrossRefGoogle Scholar
  3. 3.
    Brazil, O. V., Prado-Franceschi, O.: The nature of neuromuscular block produced by neomycin and gentamycin. Arch. int. Pharmacodyn. Ther. 179, 78 (1969).Google Scholar
  4. 4.
    Brown, R. B.: The diphasic action of halothane on the oxi-dative metabolism of drugs by the liver. Anesthesiology 35, 241 (1971).PubMedCrossRefGoogle Scholar
  5. 5.
    Byck, R.: Drugs and the treatment of psychiatric disorders. In: The pharmacological basis of therapeutics (eds. L. S. Goodman, A. Gilman), 5. Auflage. New York: Macmillan 1975.Google Scholar
  6. 6.
    Chinyanga, H. M., Stoyka, W. W.: The effect of colimycin M, gentamycin and kanamycin on depression of neuromuscular transmission induced by pancuronium bromide. Canad. Anaesth. Soc. J. 21, 569 (1974).PubMedCrossRefGoogle Scholar
  7. 7.
    Daunderer, M.: Physostigmine salicylate as an antidote. Int. J. Clin. Pharmacol. Ther. Toxicol. 18, 523 (1980).PubMedGoogle Scholar
  8. 8.
    Dennhardt, R., Konder, H.: Wechselwirkungen zwischen Diaze-pam, Ketamine, Inhalationsanästhetika und Bupivacain. Vortrag Symposium: Neue Aspekte in der Regionalanästhesie. Düsseldorf 1979.Google Scholar
  9. 9.
    Dundee, J. W., Haslett, H. K., Keilty, S. R., Pandit, S. K.: Studies of drugs given before anaesthesia. XX. Diazepam-containing mixtures. Brit. J. Anaesth. 42, 143 (1970).PubMedCrossRefGoogle Scholar
  10. 10.
    Forster, A., Gardaz, J. P., Suter, P. M., Gemperle, M.: Respiratory depression by midazolam and diazepam. Anesthe-siology 52, 494 (1980).CrossRefGoogle Scholar
  11. 11.
    Laflin, M. J.: Interaction of pancuronium and corticoste-roids. Anesthesiology 47, 471 (1977).PubMedCrossRefGoogle Scholar
  12. 12.
    Landau, E. M.: Function and structure of the ACh-receptor at the muscle end-plate. Progr. Neurobiol. 10, 253 (1979).CrossRefGoogle Scholar
  13. 13.
    Lee, C., Chen, D., Nagel, E. L.: Neuromuscular block by antibiotics: Polymyxin B. Anesth. Analg. Curr. Res. 56, 373 (1977).Google Scholar
  14. 14.
    Miller, R. D., Booij, L. H. D. J., Agoston, S., Crul, J. F.: 4-Aminopyridine potentiates neostigmine and pyridostigmine in man. Anesthesiology 50, 416 (1979).PubMedCrossRefGoogle Scholar
  15. 15.
    Mohler, H., Okada, T.: Benzodiazepine receptor: demonstration in the central nervous system. Science 198, 849 (1977).PubMedCrossRefGoogle Scholar
  16. 16.
    Riecker, G.: Interactions of drugs used in intensive medicine. Vortrag 7th World Congress of Anaesthesiologists. Hamburg 1980..Google Scholar
  17. 17.
    Schuh, F. T.: Zur Cholinesterase-Hemmung durch Pancuronium. Anaesthesist 26, 125 (1977).PubMedGoogle Scholar
  18. 18.
    Singh, Y. N., Marshall, I. G., Harrey, A. L.: Some effects of the aminoglycoside antibiotic amikacin on neuromuscular and autonomic transmission. Brit. J. Anaesth. 50, 109 (1978).PubMedCrossRefGoogle Scholar
  19. 19.
    Waser, P. G., Lüthi, U.: Verteilung, Metabolismus und Elimination von 3H-Diallyl-nor-toxiferin (Alloferin) bei Katzen. Helv. physiol. Acta 24, 259 (1966).Google Scholar
  20. 20.
    Waterman, P. M., Smith, R. B.: Tobramycin-curare interaction. Anesth. Analg. Curr. Res. 56, 587 (1977).Google Scholar
  21. 21.
    Wand, B. E.: Decrease in dose requirement of d-tubocurarine by volatile anesthetics. Anesthesiology 51, 298 (1979).CrossRefGoogle Scholar
  22. 22.
    Wright, J. M., Collier, B.: The site of the neuromuscular block produced by polymyxin B and rolitetracycline. Canad. J. Physiol. Pharmacol. 54, 926 (1976).CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin · Heidelberg 1982

Authors and Affiliations

  • R. Dennhardt

There are no affiliations available

Personalised recommendations